Market Place
Sourcing Support
Fortrea Releases Inaugural Corporate Social Responsibility Report
17 Oct 2024 //
GLOBENEWSWIRE
Amicus Therapeutics Announces Q2 2024 Results And Corporate Updates
08 Aug 2024 //
GLOBENEWSWIRE
Amicus Announces Issuance of New U.S. Composition of Matter Patent for Galafold
19 Apr 2022 //
GLOBENEWSWIRE
Amicus spins off gene therapy unit in $600M SPAC deal
30 Sep 2021 //
FIERCEBIOTECH
Chiesi’s flagship Fabry drug heads for FDA verdict in early 2021
13 Aug 2020 //
PHARMAPHORUM
Amicus, Penn expand gene therapy research agreement into five-year collaboration
30 May 2019 //
ENDPTS
2018 Drug Approvals: A Closer Look
05 Feb 2019 //
SCIENCE MAG BLOG
Orphan drugs from Biogen and Amicus win UK Prix Galien
17 Nov 2018 //
PM LIVE
FDA Approves Eight Novel Drugs in August
03 Sep 2018 //
BIOSPACE
FDA Approves Galafold (migalastat) for Fabry Disease
11 Aug 2018 //
CNBC
New management offers Amicus a warm embrace and marketing OK for Galafold
10 Aug 2018 //
ENDPTS
FDA approves new treatment for a rare genetic disorder, Fabry disease
10 Aug 2018 //
FDA
Amicus Therapeutics Launches Galafold® (Migalastat) for Fabry Disease in Japan
30 May 2018 //
PRESS RELEASE
Amicus`s to Present at LEERINK Partners 7th Annual Global Healthcare Conference
13 Feb 2018 //
PRESS RELEASE
Once rejected, FDA now rolls out a short red carpet for Amicus’ migalastat
13 Feb 2018 //
ENDPTS
Amicus`s Launches Galafold™ for Treatment of Fabry Disease in Spain
27 Jan 2018 //
PRESS RELEASE
Amicus to Present at LEERINK Partners Roundtable Rare Disease & Immuno-Oncology
20 Sep 2017 //
PRESS RELEASE
Amicus scraps top rare disease drug after it flunks pivotal test & shares spike
14 Sep 2017 //
ENDPTS
Amicus Therapeutics Launches Galafold™ (Migalastat) for Treatment of Fabry Disease in Italy
09 Mar 2017 //
GLOBENEWSWIRE
Amicus kicks off launch of Galafold in the UK
28 Feb 2017 //
PHARMATIMES
Amicus gets NICE green light for Fabry drug
23 Feb 2017 //
PMLIVE
NICE backs Amicus’ Galafold for Fabry disease
04 Jan 2017 //
PHARMATIMES
Amicus Plummets on 3-Year Delay to U.S. Fabry Drug FDA Filing Plan
29 Nov 2016 //
BIOSPACE
Amicus Therapeutics Announces US Regulatory Pathway for Migalastat
28 Nov 2016 //
GLOBENEWSWIRE
Amicus`s Fabry disease drug gets positive EU recommendation
01 Apr 2016 //
REUTERS
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.